Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

• Eline J.M. Bertrums,
• C. Michel Zwaan,
• Daisuke Hasegawa,
• Valerie de Haas,
• Dirk N. Reinhardt,
• Franco Locatelli,
• Barbara de Moerloose,
• Michael Dworzak,
• Arjan Buijs,
• Petr Smisek,
• Alexandra Kolenova,
• Cornelis Jan Pronk,
• Jan-Henning Klusmann,
• Ana Carboné,
• Alina Ferster,
• Evangelia Antoniou,
• Soheil Meshinchi,
• Susana C. Raimondi,
• Charlotte M. Niemeyer,
• Henrik Hasle,
• Marry M. van den Heuvel-Eibrink,
• Bianca F. Goemans

Affiliations

Eline J.M. Bertrums

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC, Rotterdam, the Netherlands; Oncode Institute, Utrecht

C. Michel Zwaan

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC, Rotterdam

Daisuke Hasegawa

Department of Pediatrics, St. Luke’s international Hospital, Tokyo

Valerie de Haas

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Dutch Childhood Oncology Group (DCOG), Utrecht

Dirk N. Reinhardt

Department of Pediatric Oncology, University of Duisburg-Essen, Essen

Franco Locatelli

Sapienza, University of Rome Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Children’s Hospital, Rome

Barbara de Moerloose

Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent

Michael Dworzak

Children's Cancer Research Institute and St. Anna Kinderspital, Department of Pediatrics, Medical University of Vienna, Vienna

Arjan Buijs

Department of Genetics, University Medical Center, Utrecht

Petr Smisek

Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague

Alexandra Kolenova

Department of Pediatric Hematology and Oncology, Comenius University Children's Hospital, Bratislava

Cornelis Jan Pronk

Childhood Cancer Center, Skåne University Hospital, Lund

Jan-Henning Klusmann

Pediatric Hematology, Oncology and Hemostaseology, Hospital for Children and Adolescents, University Hospital of Frankfurt/Main, Goethe-University Frankfurt/Main, Frankfurt

Ana Carboné

Department of Pediatric Onco-Hematology, University Hospital Miguel Servet, Zaragoza

Alina Ferster

Department of Hemato-Oncology, Immunology and Transplantation, University Pediatric Hospital Reine Fabiola (ULB), Brussels

Evangelia Antoniou

Department of Pediatric Oncology, University of Duisburg-Essen, Essen

Soheil Meshinchi

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA

Susana C. Raimondi

Department of Pathology, St. Jude Children’s Hospital, Memphis, TN

Charlotte M. Niemeyer

Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg

Henrik Hasle

Department of Pediatrics, Aarhus University Hospital, Aarhus

Marry M. van den Heuvel-Eibrink

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands University of Utrecht, Utrecht

Bianca F. Goemans

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Dutch Childhood Oncology Group (DCOG), Utrecht